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Abstract
Background: Hepatocellular carcinoma (HCC) is the most common type of tumor and is associated with high
morbidity and mortality rates. Patients with HCC routinely undergo surgery followed by adjuvant radiation therapy
and chemotherapy. Despite such aggressive treatment approaches, median survival times remain under 1 year in
most cases. KDM5C is a member of the family of JmjC domain-containing proteins that removes methyl residues
from methylated lysine 4 on histone H3 lysine 4 (H3K4). KDM5C has been proposed as an oncogene in many types
of tumors; however, its role and underlying mechanisms in HCC remain unclear.
Methods: Expression level of KDM5C was examined by RT-PCR, and IHC. Forced expression of KDM5C was mediated
by retroviruses, and KDM5C was downregulated by shRNAs expressing lentiviruses. Migration and invasion of HCC cells
was measured by wound healing, Transwell and Matrigel assays respectively.
Results: In this study, we report that KDM5C is abundantly expressed in invasive human HCC cells. Cellular depletion
of KDM5C by shRNA inhibited HCC cell migration, invasion and epithelial-mesenchymal transition in vitro, and markedly
decreased the metastasis capacity of invasive HCC cells in the liver and lung. Furthermore, ectopic expression of KDM5C
in HCC cells promoted cell migration, invasion and epithelial-mesenchymal transition via the inactivation of BMP7.
Knockdown of BMP7 significantly promotes shKDM5C-induced cell migration inhibition.
Conclusions: Taken together, these data suggest that KDM5C-mediated BMP7 inactivation is essential for HCC cell
invasion.
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Background
Hepatocellular carcinoma (HCC) is a highly aggressive
tumor characterized by its lack of response to conven-
tional chemo-, radio-, and immunotherapies [1]. HCC
cells extensively invade normal tissues, which contribute
to the continued poor prognosis for these tumors by
preventing complete surgical resection [2, 3]. Invading
tumor cells are resistant to conventional therapies and
invasiveness is enhanced by antiangiogenic approaches
[4, 5]. Thus, an effective strategy to prevent invasion of
HCC cells into surrounding normal tissues is needed.
Lysine (K)-specific demethylase 5C (KDM5C) is a
member of the family of JmjC domain-containing pro-
teins that specifically removes methyl residues from tri-,
di-, and monomethylated lysine 4 on histone H3 lysine 4
(H3K4) that are associated with active genes [6]. KDM5C is
a transcriptional repressor that harbors intrinsic histone
demethylase activity [7]. Trimethylation at H3K4 is an
important histone mark associated with actively transcribed
genes, and KDM5C specifically demethylates H3K4me3
to a transcriptionally inactive state [8]. KDM5C is up-
regulated in multiple tumor cell lines [9–11]. Further-
more, KDM5C promotes proliferation of cancer cells,
and knockdown of KDM5C causes a significant delay in
the G1/S transition [12, 13]. KDM5C appears to
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promote tumorigenesis through the specific repression
of antiproliferative genes [14, 15]. Thus, KDM5C may
act as an oncogene, but whether KDM5C plays a role
in HCC metastasis remains unknown.
Bone morphogenetic proteins (BMPs) signal via spe-
cific serine/threonine kinase receptors on the cell surface
known as bone morphogenetic protein receptors
(BMPRs) [16]. Both type-I and -II BMPRs are required
for signal transduction. The type-I receptor BMPRIA
preferentially binds ligands of the Dpp class, such as
BMP2 and BMP4, whereas the type-II receptor BMPRIB
binds ligands of the 60A class, such as BMP7 [16–18].
After ligand binding, the type-I/type-II receptor complex
phosphorylates Smad1, 5 and 8 proteins that translocate
to the nucleus to regulate target gene expression [19].
Previous studies have shown that BMP-7 exert anti-
invasive actions by inhibiting TGF-beta-induced expres-
sion of integrin beta [20, 21].
In the current study, we show that KDM5C overexpres-
sion predicts poor prognosis in HCC patients undergoing
curative resection. Additionally, we present the evidence
that KDM5C expression promotes HCC cells invasion, me-
tastasis and EMT. These functional effects of KDM5C
were exerted through control of BMP7 transcriptional ex-
pression via H3K4me3. The down-regulation of BMP7
triggered by KDM5C therefore enforces HCC cells onco-
genesis and metastasis. Our findings provide a novel mech-
anistic role of KDM5C in HCC metastasis, suggesting that




Lipofectamine 2000 transfection and TRIZOL LS Re-
agents were purchased from Invitrogen (Grand Island,
NY, USA). Antibodies against KDM5C, Histone H3,
H3K4me1 (monomethylated K4), H3K4me2 (dimethy-
lated K4), H3K4me3 (trimethylated K4), H3K27me3
(trimethylated K27) were purchased from Abcam
(Cambridge, MA, USA). E-cadherin, N-cadherin, vimentin,
BMP7, and β-actin antibodies were from Cell Signaling
technology (Danvers, MA, USA). Anti-α-catenin antibody
was from BD (Franklin Lakes, NJ, USA).
Patients and specimens
Eighteen tumor and para-cancerous tissues which, were
used for qRT-PCR analysis, were randomly collected
from HCC patients who underwent curative resection
with informed consent between 2013 and 2014 at the
department of laparoscopic surgery, First Affiliated Hos-
pital of Dalian Medical University. All tissues were col-
lected immediately upon resection of the tumors in the
operation theater, transported in liquid nitrogen, and then
stored at −80 °C. Another 221 hepatocellular carcinoma
tissues which, were used for immunohistochemical ana-
lysis, were randomly collected from HCC patients who
underwent curative resection with informed consent be-
tween 2008 and 2014 at the Department of Hepatobiliary
Surgery, First Affiliated Hospital of Dalian Medical Uni-
versity. Tumor staging was based on the 6th edition of the
tumor-node-metastasis (TNM) classification of the Inter-
national Union Against Cancer. The clinicopathologic
characteristics of the 221 hepatocellular carcinoma tissues
are summarized in Table 1. Follow-up data were summa-
rized at the end of March 2015, with a median observation
time of 62.4 months. Study protocols were approved by
the Hospital Ethics Committee of Dalian Medical Univer-
sity, and written informed consent was obtained from pa-
tients based on the Declaration of Helsinki.
Histological and immunohistochemical analysis
The normal human liver tissues, human tumor tissues,
and lungs dissected from mice were fixed in 4 % parafor-
maldehyde in phosphate-buffered saline (PBS) overnight
and subsequently embedded in paraffin wax. Sections cut
at a thickness of 4 μm were stained with hematoxylin and
eosin for histological analysis. Immunohistochemical
analysis was performed for different markers in these
arrays as described previously. The proportion of
stained cells (lower, <30 % staining; higher, ≥30 % staining)
was semiquantitatively determined following published
protocols [22, 23].
Cell culture
HCC cells (ATCC, Manassas, VA, USA) were cultured
under the following conditions: Huh7, and MHCC97L
cell lines were cultured using 10 % fetal bovine serum
(Cat#10099-141, Invitrogen, Carlsbad, CA) in either
RPMI-1640 (Cat#C11875, Invitrogen). L02 cell lines
were cultured using 10 % fetal bovine serum (Invitrogen)
in Dulbecco’s modified Eagle medium (Cat#C11965, Invi-
trogen). Cell culture was according to manufacturer’s
protocol. All the cell lines were grown at 37 °C in a 5 %
CO2/95 % air atmosphere and were revived every 3 to
4 months.
Establishment of KDM5C and BMP7 stable expression and
KDM5C and BMP7 knockdown cell lines
Retroviral construct containing human pBabe-KDM5C
cDNA, pcDNA3.1-BMP7 cDNA and pSuper.retro.puro
with shRNA against human KDM5C and siBMP7 were
prepared as described previously [22, 24]. The generation
of retrovirus supernatants and transfection of hepatocellu-
lar carcinoma cells were conducted as described previ-
ously [22, 25]. The expression of KDM5C and BMP7 was
confirmed by qRT-PCR and Western blotting analysis.
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Wound healing assay
Cells were seeded in 6 cm culture plates, and the cell
monolayers were wounded by scratching with sterile
plastic 200 μl micropipette tips and photographed using
phase-contrast microscopy. The migration distance of
each cell was measured after the photographs were con-
verted to Photoshop files.
Cell invasion and motility assay
Invasion of cells was measured in Matrigel (BD, Franklin
Lakes, NJ, USA) -coated Transwell inserts (6.5 mm,
Costar, Manassas, VA, USA) containing polycarbonate
filters with 8-μm pores as detailed previously. The in-
serts were coated with 50 μl of 1 mg/ml Matrigel
matrix according to the manufacturer’s recommenda-
tions. 2 × 105 cells in 200 μl of serum-free medium
were plated in the upper chamber, whereas 600 μl of
medium with 10 % fatal bovine serum were added to
lower well. After 24 h incubation, cells that migrated
to the lower surface of the membrane were fixed and
stained. For each membrane, five random fields were
counted at × 10 magnification. Motility assays were
similar to Matrigel invasion assay except that the
Transwell insert was not coated with Matrigel.
Western blotting
Cells were lysed in lysis buffer and total protein contents
were determined by the Bradford method. 30 μg of lysis
were separated by reducing SDS-PAGE and probed with
specific antibodies. Blots were washed and probed with re-
spective secondary peroxidase-conjugated antibodies, and
the bands visualized by chemoluminescence (Amersham
Biosciences).
qRT-PCR
Total RNA was extracted using Trizol reagent and cDNA
was synthesized using SuperScript II Reverse Transcript-
ase (Invitrogen). qRT-PCR and data collection were per-
formed with an ABI PRISM 7900HT sequence detection
system. The primers used for the amplification of the indi-
cated genes are available in Additional file 1: Table S1.
Gene expression profiling
Total RNA quality and quantity were determined using
Agilent 2100 Bioanalyzer and NanoDrop ND-1000. Affy-
metrix HU U133 plus 2.0 arrays were used according to
manufacturer’s protocol. The data were initially normal-
ized by robust multiarray average (RMA) normalization
algorithms in expression console software (Affymetrix).
Significantly altered genes between KDM5C overexpres-
sion and its control cells were considered by scatter
plots and the genes up- and down-regulated ≥5-fold.
Clustering analysis was done using gene list by Gene
Cluster v3.0 software, and heat maps were visualized
using Java TreeView v1.1.4r3 software. Gene set en-
richment analysis was carried out using ConceptGen
(http://conceptgen.ncibi.org/core/conceptGen/index.jsp).
Table 1 KDM5C staining and clinicopathologic characteristics of
221 hepatocellular carcinoma patients
Variables KDM5C staining Total P*
Low High
Age (y) 0.513
≤ 50 61 (73 %) 22 (27 %) 83
> 50 99 (72 %) 39 (28 %) 138
Sex 0.405
Male 133 (73 %) 49 (27 %) 182
Female 31 (79 %) 8 (21 %) 39
HBsAg 0.072
Negative 46 (80 %) 11 (20 %) 57
Positive 115 (60 %) 49 (40 %) 164
HCV 0.169
Negative 139 (66 %) 72 (34 %) 211
Positive 8 (80 %) 2 (20 %) 10
AFP 0.534
≤ 20 73 (75 %) 25 (25 %) 98
> 20 91 (74 %) 32 (26 %) 123
γ-GT(U/L) 0.187
≤ 54 72 (67 %) 36 (33 %) 108
> 54 81 (72 %) 32 (28 %) 113
Liver cirrhosis 0.566
No 29 (69 %) 13 (31 %) 42
Yes 122 (68 %) 57 (32 %) 179
Tumor diameter (cm) 0.028
≤ 5 133 (68 %) 62 (32 %) 195
> 5 12 (46 %) 14 (54 %) 26
Microvascular invasion <0.001
Absence 74 (80 %) 19 (20 %) 93
Present 53 (41 %) 75 (59 %) 128
Tumor encapsulation 0.096
Complete 78 (74 %) 27 (26 %) 105
None 77 (66 %) 39 (34 %) 116
Tumor differentiation <0.001
I + II 115 (73 %) 42 (27 %) 157
III + IV 26 (41 %) 38 (59 %) 64
TNM stage 0.139
I 121 (64 %) 68 (36 %) 189
II + III 23 (72 %) 9 (28 %) 32
HBsAg hepatitis B surface antigen, AFP α-fetoprotein, γ-GT γ-glutamyl transferase,
TNM tumor-nodesmetastasis
*p-value < 0.05 was considered statistically significant. p-values were calculated
using the Pearson chi-square test
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Gene sets were either obtained from the ConceptGen or
from published gene signatures.
Chromatin immunoprecipitation (ChIP)-qPCR
Chromatin Immunoprecipitation kit (Cat. 17–371) was
purchased from Millipore and ChIP experiments were
carried out essentially as described [26]. Immnuoprecipi-
tated DNA was analyzed on the ABI PRISM 7900HT se-
quence detection system. The primers used for detection
of promoters after ChIP are available upon request.
In vivo tumor metastasis assays
Nude mice were purchased from the Shanghai Slac La-
boratory Animal Co. Ltd and maintained in microisola-
tor cages. All animals were used in accordance with
institutional guidelines and the current experiments
were approved by the the Dalian Medical University Ex-
perimental Animal Care Commission. For metastasis as-
says, cells were resuspended in PBS at a concentration
of 1×107 cells ml−1. Cell suspension (0.1 ml) was injected
into tail veins of nude mice. All of the mice were killed
by CO2 60 days after inoculation.
Statistical analysis
Results were analyzed with SPSS13.0 statistical software.
Correlation between KDM5C expression and clinico-
pathologic parameters was evaluated using the Chi-
square (χ2) test, and quantitative variables were analyzed
by the independent t test. The survival probability was
estimated by Kaplan-Meier method, and the comparison
of survival curves between groups was done with the
log-rank test. The statistical significance of the differ-
ences between mean values was determined by P < 0.05.
Results
KDM5C is highly expressed and correlated with distant
metastasis in HCC
To investigate whether KDM5C might be involved in
HCC, the mRNA expression level of KDM5C in HCC tis-
sues and its matched normal adjacent liver tissues was
determined by qRT-PCR in 18 samples. As compared with
normal liver tissues, HCC specimens showed overexpres-
sion of KDM5C (Fig. 1a and b). We then analyzed
KDM5C protein expression in more HCC samples by
IHC. We observed that the level of KDM5C positive cells
was markedly higher in HCC tissues than the level in the
normal liver tissues (Fig. 1c). Most importantly, KDM5C
overexpression was consistently significantly correlated to
distant metastasis in these HCC samples (Fig. 1c and d).
To investigate the relationship between KDM5C expres-
sion and clinicopathological parameters in the 221 cases
with HCCs, these cases were first divided into two sub-
groups: “low KDM5C expression” and “high KDM5C ex-
pression” as defined in the immunohistochemistry section
of “Materials and methods”. Significant correlations were
found between KDM5C expression and tumor diameter,
microvascular invasion, and tumor differentiation. There
were no statistical connections between KDM5C expres-
sion and the rest clinicopathological parameters, such as
patient age, gender, and HBsAg (Table 1). The association
between KDM5C expression in HCC and the survival time
of selected patients was analyzed with Kaplan-Meier sur-
vival analysis (Fig. 1e). The median overall survival time of
high KDM5C expression group was significantly shorter
than that of low KDM5C expression group (P < 0.001).
These results collectively indicate a functional role of
KDM5C in aggressive behaviors of HCCs.
Transfection efficiency of KDM5C in HCC cell lines
We next analyzed the expression of KDM5C in the im-
mortalized normal human liver cell line, L02, and HCC
cell lines Huh7 and MHCC97L. Significantly higher ex-
pression of KDM5C protein (Fig. 2a) and mRNA (Fig. 2b)
was evident in Huh7 and MHCC97L cell lines than in
immortalized normal human liver cell line L02. The
KDM5C expression plasmid pBabe-KDM5C was trans-
fected into 02 cells. After selection with puromycin,
KDM5C expression was assayed by western blot (Fig. 2c)
and qRT-PCR (Fig. 2d). MHCC97L is a highly invasive
HCC cell line commonly used in HCC research. This
cell line was infected with pSuper-shKDM5C or the con-
trol (pSuper) to investigate the effect of KDM5C knock-
down on the migration and invasion of HCC cells.
Western blot (Fig. 2e), and qRT-PCR (Fig. 2f ) demon-
strated that the protein and mRNA expression level of
KDM5C was significantly suppressed in the cells in-
fected with pSuper-shKDM5C.
KDM5C promotes migratory and invasive capacities of
HCC cells in vitro
The effect of KDM5C on HCC cell migration was first
assessed by wound healing assay. L02-pBabe-KDM5C
cells had significantly faster closure of the wound area
compared to control cells (Fig. 3a). This result was con-
firmed by Boyden’s chamber assay (Fig. 3b). Moreover,
L02-pBabe-KDM5C cells showed a greater degree of in-
vasion through Matrigel (Fig. 3b). In contrast, silencing
KDM5C dramatically reduced the migratory and inva-
sive capacity of MHCC97L cells (Fig. 3c and d). These
results indicate that KDM5C promotes migratory and
invasive behaviors in HCC cells in vitro.
KDM5C promotes HCC cells metastasis in vivo
We then investigated the functional relevance of KDM5C
for metastasis in vivo. L02-pBabe-KDM5C, MHCC97L-
pSuper-shKDM5C and their corresponding control cells
were injected into nude mice through the tail vein.
KDM5C overexpression not only significantly increased
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Fig. 1 (See legend on next page.)
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Fig. 2 Transfection efficiency of KDM5C in HCC cell lines. a Expression of KDM5C protein was measured by Western blotting in L02, Huh7 and
MHCC97L cell lines. b expression of KDM5C mRNA was measured by qRT-PCR in L02, Huh7 and MHCC97L cell lines. c The transfection efficiency
of KDM5C in L02 cells was analyzed by western blot. d The transfection efficiency of KDM5C in L02 cells was analyzed by qRT-PCR. e The transfection
efficiency of KDM5C shRNA or control vector in MHCC97L cells were analyzed by western blot. f the transfection efficiency of KDM5C shRNA or control
vector in MHCC97L cells were analyzed by qRT-PCR. **, P < 0.01 is based on the Student t test. All results are from three independent experiments. Error
bars, SD
(See figure on previous page.)
Fig. 1 KDM5C is highly expressed in HCC. a KDM5C mRNA expression was analyzed by quantitative RT-PCR in tumors and adjacent tissues. b Comparison of
the expression levels of KDM5C mRNA in adjacent normal tissues, and HCCs. c KDM5C protein expression was analyzed by immunohistochemical analysis in
221 cases HCC tissues and the representative results were shown. d semiquantification of KDM5C expression in normal tissues, no-invasive HCC and invasive
HCC tissues. e The association between KDM5C expression in HCC and the survival time of selected patients was analyzed with Kaplan-Meier
survival analysis. Scale bars, 50 μm (upper) and 20 μm (lower) in C. **, P < 0.01 is based on the Student t test. All results are from three independent
experiments. Error bars, SD
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the number of mice with distant metastasis (Fig. 4e), but
also dramatically increased the number of metastatic tu-
mors in both lung and liver of each mouse (Fig. 4a and b).
Silencing KDM5C in MHCC97L cells inhibited metastatic
behavior, both in terms of the number of mice with distant
metastasis (Fig. 4e) and the number of metastatic tumors
in the lung and liver of each mouse (Fig. 4c and d). There-
fore, the in vivo results further demonstrate the critical
role of KDM5C in HCC cells metastasis.
KDM5C regulates the transition between epithelial and
mesenchymal phenotypes in HCC cells
We then observed the cells morphological changes and
found that L02-pBabe-KDM5C cells exhibited fibroblas-
tic morphology (Fig. 5a). This observation was further
confirmed by expression analyses of epithelial and
mesenchymal markers. We showed that KDM5C over-
expression decreased the levels of epithelial markers
(E-cadherin and α-catenin) and increased the levels of
mesenchymal markers (N-cadherin and vimentin) in
cell lines (Fig. 5b and c). Conversely, MHCC97L-pSuper-
shKDM5C cells reverted to an epithelial phenotype as
compared to their respective control cells (Fig. 5d). Con-
sistent with this, silencing KDM5C increased levels of epi-
thelial markers, and decreased levels of mesenchymal
markers (Fig. 5e and f). Taken together, these findings sug-
gest that KDM5C plays an important role in regulating
EMT-MET plasticity of HCC cells.
KDM5C regulates BMP7 expression through H3K4
trimethylation
To better understand the mechanisms by which KDM5C
engaged in HCC development and progression, we per-
formed gene expression profiling on L02-pBabe-KDM5C
and its control cells. Microarray analyses identified a list of
genes significantly differentially expressed after KDM5C
overexpression including downregulation of BMP7 (Fig. 6a).
Furthermore, gene set enrichment analysis indicated that
proliferation, neoplasm metastasis and invasion, cell move-
ment and motility, and BMP7 related gene signatures were
significantly changed in KDM5C overexpression cells
(Fig. 6b), supporting the idea that KDM5C regulates
proliferation, EMT and cancer invasion and metastasis.
These data also led us to hypothesize that KDM5C
exerts these functions possibly via BMP7. To test this,
we first determined whether BMP7 is a downstream
target of KDM5C in HCC cells. Expression of BMP7
in the cells with altered KDM5C expression was fur-
ther evaluated by Western blotting and qRT-PCR.
L02-pBabe-KDM5C cells exhibited greatly decreased
both BMP7 protein and mRNA levels (Fig. 6c and d),
whereas silencing KDM5C in MHCC97L cells dramat-
ically increased its mRNA and protein levels (Fig. 6e
and f ).
We then explored how KDM5C regulates BMP7 expres-
sion at the transcriptional level. KDM5C complexes are fre-
quently involved in chromatin regulation [27, 28]. To
determine whether KDM5C regulates specific histone mod-
ifications in HCC cells, histone modification patterns were
measured after modulation of KDM5C expression. Among
histone H3K4 and H3K27, we found that only H3K4 was
affected by KDM5C. Ectopic expression of KDM5C de-
creased H3K4me1, H3K4me2, and H3K4me3 while silen-
cing of KDM5C increased these modifications (Fig. 7a).
Because H3K4me3 is associated with active transcription,
we tested whether KDM5C expression was correlated with
the H3K4me3 modification at the BMP7 gene promoter in
HCC cells (Fig. 7b). Quantitative chromatin immunopre-
cipitation (qChIP) assays were performed in L02-
pBabe-KDM5C and its corresponding control cells. We
found that KDM5C expression was associated with de-
creased H3K4me3 levels at region −548 to −316 bp
(Fig. 7B2) and +682 to +891 bp (Fig. 7B2) of the BMP7 pro-
moter in L-02-pBabe-KDM5C cells (Fig. 7c and d). More
occupancy of those BMP7 gene promoter regions by
H3K4me3 was detected in MHCC97L-pSuper-shKDM5C
cells (Fig. 7e and f). The occupancy of chromatin repressors
such as H3K27me3 at the BMP7 gene promoter was not
changed by altered CUL4A expression (Additional file 2:
Figure S1). These results clearly indicate that KDM5C in-
duces transcriptional inactivation of BMP7 through regu-
lating H3K4me3 and decreasing H3K4me3 to the BMP7
gene promoter. On the basis of the indispensable role of
BMP7 in the biologic functions of KDM5C, we silenced
BMP7 in MHCC97L-pSuper-shKDM5C cells (Fig. 8a
and b). Of note, silencing BMP7 in MHCC97L-pSuper-
shKDM5C cells significantly increased the migration
and invasion (Fig. 8c). Taken together, these results
(See figure on previous page.)
Fig. 3 KDM5C promotes migratory and invasive capacities of HCC cells in vitro. a L02-pBabe-KDM5C and its control vector cells were subjected to wound
healing assays; the uncovered areas in the wound healing assays were quantified as a percentage of the original wound area. b L02-pBabe-KDM5C and its
control vector cells were subjected to Transwell migration (top), and Matrigel invasion assays (bottom), quantification of migrated cells
through the membrane and invaded cells through Matrigel of each cell line are shown as proportions of their vector controls. c MHCC97L-
pSuper-shKDM5C and its control vector cells were subjected to wound healing assays, the uncovered areas in the wound healing assays
were quantified as a percentage of the original wound area. d MHCC97L-pSuper-shKDM5C and its control vector cells were subjected to
Transwell migration (top), and Matrigel invasion assays (bottom), quantification of migrated cells through the membrane and invaded cells
through Matrigel of each cell line are shown as proportions of their vector controls. **, P < 0.01 is based on the Student t test. All results
are from three independent experiments. Error bars, SD
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show that BMP7 mediates KDM5C-induced migration
and invasion in hepatocellular carcinoma cells.
Discussion
Hepatocellular carcinoma (HCC) is the fifth most common
malignancy in the world and the second leading cause of
cancer death in Asia [1]. The high mortality rate of HCC is
caused by frequent tumor metastasis, postsurgical recur-
rence, and late detection at advanced stages [5]. HCC is as-
sociated with multiple risk factors and is now recognized
as a both genetic and epigenetic disease [29, 30]. While the
sequential accumulation of various genetic changes in
hepatocarcinogenesis has been extensively studied, the
contribution of epigenetic alterations to HCC development
and progression has remained relatively poorly understood.
Histone methylation is a dynamic epigenetic process that
participates in a diverse array of cellular processes and has
been found to associate with cancer, including HCC [13].
Recently, several histone demethylases have been iden-
tified that catalyze the removal of methylation from his-
tone H3 lysine residues [13, 31]. Previous studies had
found that KDM5C, also named JARID1C, as a histone
demethylase that can catalyze the removal of all three
methyl groups from the H3K4 lysine residue [7]. How-
ever, its role and underlying mechanisms in HCCs still
unknown.
Fig. 4 KDM5C promotes HCC cells metastasis in vivo. a The numbers of metastatic foci per section in lung of individual mouse with injection
of L02-pBabe-KDM5C or its control cells. b The numbers of metastatic foci per section in liver of individual mouse with injection of L02-pBabe-
KDM5C or its control cells. c The numbers of metastatic foci per section in lung of individual mouse with injection of MHCC97L-pSuper-shKDM5C
or its control cells. d The numbers of metastatic foci per section in liver of individual mouse with injection of MHCC97L-pSuper-shKDM5C or its
control cells. e The total numbers of mice with distant metastasis at 60 days after injection of L02-pBabe-KDM5C, MHCC97L-pSuper-shKDM5C or
their control cells. n = 6 for subcutaneous transplantation and n = 5 for tail vein injection. **, P < 0.01 is based on the Student t test. All results are
from three independent experiments. Error bars, SD
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To our knowledge, this is the first research to show
that KDM5C plays an important role in HCC. We
found that as compared with normal tissues, HCC
specimens showed overexpression of KDM5C and its
overexpression was significantly correlated with distant
metastasis in HCC tissues. High expression of KDM5C
was associated with decreased overall survival of HCC
patients. KDM5C overexpression in HCC cells induced
Fig. 5 KDM5C regulates the transition between epithelial and mesenchymal phenotypes in HCC cells. a Representative phase-contrast images of L02
cells showed KDM5C overexpression-modulated morphologic changes. b expression of epithelial and mesenchymal marker was analyzed by Western
blotting in L02-pBabe-KDM5C and its control cells. c Expression of epithelial and mesenchymal marker was analyzed by qRT-PCR in L02-pBabe-KDM5C
and its control cells. d Representative phase-contrast images of MHCC97L cells showed KDM5C knockdown-modulated morphologic changes.
e Expression of epithelial and mesenchymal marker was analyzed by Western blotting in MHCC97L-pSuper-shKDM5C and its control cells.
f expression of epithelial and mesenchymal marker was analyzed by qRT-PCR in MHCC97L-pSuper-shKDM5C and its control cells. **, P < 0.01 is
based on the Student t test. All results are from three independent experiments. Error bars, SD
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EMT, migration, invasion in vitro and enhanced meta-
static capacities in vivo. In contrast, silencing KDM5C re-
versed these events in invasive HCC cells. We also
showed that a mechanistic link between KDM5C and
BMP7 through KDM5C-mediated regulation of H3K4m3,
which subsequently leads to transcriptional downregula-
tion of BMP7 expression. These results lead us to propose
a model for KDM5C regulation of EMT and metastasis
through transcriptional regulation of BMP7 in HCCs.
Histone lysine demethylases (KDMs) are epigenetic en-
zymes that can remove both repressive and activating his-
tone marks [32]. KDM5 family members are capable of
removing the histone H3 lysine 4 dimethylation-activating
marks, rendering them potential players in the down-
regulation of tumor suppressors and suggesting that their
activity could repress oncogenes [32]. Histone demethy-
lase KDM5C is required for proper DNA replication at
early origins [33]. KDM5C dictates the assembly of the
Fig. 6 KDM5C downregulates BMP7 expression in HCC cells. a Supervised hierarchical clustering of the genes differentially expressed after
KDM5C overexpression in L02 cells. b Gene set enrichment analysis was carried out using ConceptGen. c Protein level of BMP7 was measured by
Western blotting assay in L02-pBabe-KDM5C and its control cells. d, mRNA level of BMP7 was measured by qRT-PCR assay in L02-pBabe-KDM5C
and its control cells. e Protein level of BMP7 was measured by Western blotting assay in MHCC97L-pSuper-shKDM5C and its control cells. f mRNA
level of BMP7 was measured by qRT-PCR assay in MHCC97L-pSuper-shKDM5C and its control cells. **, P < 0.01 is based on the Student t test. All
results are from three independent experiments. Error bars, SD
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pre-initiation complex, driving the binding to chromatin
of the pre-initiation proteins, through the demethylation
of the histone mark H3K4me3 [14]. The putative role of
KDM5C as an oncogene in cancer development is sup-
ported by the observations that KDM5C is highly
expressed in prostate cancer and other malignant tumors
relative to normal tissues [9]. Consistent with this re-
search, in the present study we showed that overexpres-
sion of KDM5C promoted HCC cells proliferation and
enhanced tumor formation in vivo. Interestingly, our
study points to a novel function of KDM5C in HCC me-
tastasis through regulating EMT.
HCC cells with ectopic expression of KDM5C dis-
played an EMT phenotype, including the associated
stimulatory effects on migration and invasion in vitro.
Interestingly, our results indicate that KDM5C not only
promotes EMT, but silencing of KDM5C also leads to
MET. All of these characteristics induced by KDM5C in
vitro culminated to increased numbers of distant metas-
tases in vivo. These empirical findings provide a
Fig. 7 KDM5C regulates BMP7 expression through H3K4 trimethylation. a The abundance of H3 lysine methylation was assessed in HCC cells with
KDM5C overexpression or shRNA by Western blotting using whole-cell lysate; total H3 and β-actin were used as a loading control. b Schematic
presentation of three regions relative to the BMP7 transcriptional start site used as primers to test histone occupied abundance. c and d qChIP
was performed to assess H3K4me3 occupancy in L02-pBabe-KDM5C and its control cells. IgG was used as negative control. e and f, qChIP was
performed to assess H3K4me3 occupancy in MHCC97L-pSuper-shKDM5C and its control cells. IgG was used as negative control. “Percentage of input”
indicates the ratio of DNA fragment of each promoter region bound by H3K4me3 to the total amount of input DNA fragment without H3K4me3
antibody pull-down. **, P< 0.01 is based on the Student t test. All results are from three independent experiments. Error bars, SD
Ji et al. BMC Cancer  (2015) 15:801 Page 12 of 15
mechanistic framework to explain the clinical observa-
tions that HCC patients with high levels of KDM5C in
tissue samples have more chance of distant metastasis, a
significantly shorter overall and disease-free survival.
Bone morphogenetic proteins (BMPs) are secreted sig-
naling molecules belonging to the transforming growth
factor (TGF)-beta superfamily [17]. Recent studies demon-
strated that the expression patterns of BMP7 are altered in
several tumors. BMP7 is essential during development, and
more recently has also been implicated in cancer patho-
genesis [20]. The roles of several transcription factors as
EMT regulators have been extensively reported [22]. In
our effort to elucidate the mechanism how KDM5C modu-
lates EMT in HCC cells, we identified BMP7 as an effective
mediator of KDM5C-induced these phenomena. BMP7 is
one of the most frequently mutated tumor suppressors in
human cancer including HCCs [34]. BMP7 also suppresses
migration, genetic deletion of the BMP7 tumor suppressor
gene promotes cell motility, and BMP7 reconstitution
or overexpression inhibits cell motility in some cell
types [20, 35]. Mechanistically, BMP7 reduces cell motility
through a variety of pathways, and decreased ERK and
AKTare two important targets of BMP7 [36]. The mechan-
istic connection between KDM5C and BMP7 was previ-
ously unknown. In this study, we showed that modulation
of KDM5C expression altered the methylation status of
H3K4 at the BMP7 gene promoter, which in turn transcrip-
tionally controlled expression of BMP7. However, we did
not detect any influence of KDM5C expression on the
methylation status of H3K27. Thus, we conclude that
KDM5C transcriptionally inactivates BMP7 expression
through H3K4 demethylation and reduces H3K4me3 to the
BMP7 gene promoter, and consequently resulting in in-
crease in migration and invasion both in vitro and in vivo.
Conclusions
In conclusion, we found that KDM5C expression was
generally higher in HCC lesions compared with non-
tumor tissues. Our in vitro and in vivo data demonstrate
that KDM5C has a vital function in promoting cell mo-
bility, which is partially by the regulation of BMP7 ex-
pression. Thus, we propose that the candidate tumor
Fig. 8 BMP7 mediates KDM5C-induced migration and invasion in HCC cells. a Silenced BMP7 protein expression in MHCC97L-pSuper-shKDM5C
cells was measured by Western blotting. b, Silenced BMP7 mRNA expression in MHCC97L-pSuper-shKDM5C cells was measured by qRT-PCR. c MHCC97L-
pSuper-shKDM5C cells treated with siBMP7 were subjected to Transwell migration (top), and Matrigel invasion assays (bottom), quantification of migrated
cells through the membrane and invaded cells through Matrigel of each cell line are shown as proportions of their vector controls. **, P< 0.01 is based on
the Student t test. All results are from three independent experiments. Error bars, SD
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oncogene KDM5C may be an effective novel therapeutic
target in the management of HCC.
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